Contributor: ATTWN Staff
In an interesting survey done by McLaughlin and Associates in August 2025, a majority of people who have a favorable view of Planned Parenthood think the abortion pill is unsafe.
Key Takeaways:
- The majority of likely voters question the safety of the abortion pill regimen.
- 71% of respondents agreed that the FDA should require women to see a doctor before obtaining the abortion pill.
- Three in five likely voters said the abortion pill is more dangerous than advertised.
Survey Reveals Majority of Voters Believe Abortion Pill is Unsafe – Even Those Who Support Planned Parenthood
In a survey of 1,600 likely voters, only 16 percent of respondents thought the abortion pill was “ very safe”, direct evidence that the message of pro-abortion activists that the pill is “safer than Tylenol” is failing. A peer-reviewed study also demonstrates that the messaging is untrue, yet this is the first survey to show that it is not resonating.
“This survey is very encouraging news and hopefully points to a wake-up call amongst Americans who are paying attention to the stories of women who have taken the abortion pills and have suffered immensely – physically, mentally, and spiritually,” said Abby Johnson, CEO and Founder of And Then There Were None and ProLove Ministries.
Firsthand accounts of women who have taken the abortion pill can be found at www.LittlePillsThatKill.com.
About six in 10 respondents said that the abortion pill regimen of mifepristone and misoprostol was either “unsafe” or they weren’t sure of its safety.
One of the biggest surprises in the survey was that while 59% said they supported Planned Parenthood, 71% of respondents said they approve of the FDA requirement that women must visit a doctor to obtain a prescription for the abortion pill.
The FDA rushed through its approval of the abortion pill in 2000, and even then, a woman had to have three in-person doctor visits before she would be prescribed the pill. This was to confirm the correct gestational age of the baby. Doctors were required to follow up with the women and report complications. Then, during President Biden’s term, he rolled back all of these requirements, which made it a piece of cake for a woman to obtain abortion pills through the mail and without a doctor’s visit. Many pro-lifers predicted that these rollbacks would make it easy for men with bad intentions to obtain the abortion pills and use them to drug their partners, causing an abortion. And it has happened – over and over and over again.
But Americans are finally questioning the logic behind offering easy access to these abortion pills.
In the August survey, three-in-five respondents agreed that “chemical abortions are far more dangerous than advertised, and women deserve a doctor’s care to prevent serious health complications like hemorrhaging, bleeding, or infections.” Americans are clearly concerned about the safety of the abortion pill.
The FDA Is Putting Women in Danger
While the respondents in the survey are concerned about abortion pill safety, the FDA is not. Last month, they approved a new generic form of the abortion pill Mifepristone. The pill is taken with misoprostol as part of the chemical abortion pill regimen, which is how about two-thirds of all abortions happen in the United States.
“The FDA should be revoking the abortion pill, not approving a generic version. This drug isn’t penicillin or something you take for a headache – the abortion pill ends the life of a growing baby and can seriously put the health and life of the mother at risk,” said Abby Johnson, CEO and Founder of And Then There Were None and ProLove Ministries.
The largest study of women who took the abortion pill, which was released in April 2025, reveals that 1 in 10 women suffer ‘severe adverse events’ such as sepsis, hemorrhaging, infection, or another severe effect within 45 days of taking the pills, according to the Ethics and Public Policy Center. This is what the FDA has made even easier to obtain by approving a generic version of the abortion pill.
Due to this study, “Health and Human Services Secretary Robert F. Kennedy, Jr. and FDA Commissioner Marty Makary [recently] announced the agency would consider modifying the Risk Evaluation and Mitigation Strategy requirements, citing ‘recent studies raising concerns about the safety of mifepristone as currently administered.’”
“Then why did the agency just approve a generic version of a drug they know to be dangerous?” asked Johnson.